Boson Remedies Private Limited
Pharmaceutical wholesale trading and storage services for medicine and related products.
2010 | Ghaziabad, Uttar Pradesh (India) | Active
Boson Remedies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -51.50%
- Profit Growth -37.96%
- Ebitda -37.54%
- Net Worth 9.18%
- Total Assets -0.51%
About Boson Remedies
Boson Remedies Private Limited (BRPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 July 2010 and has a history of 14 years and seven months. Its registered office is in Ghaziabad, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Uma Sharma, Himanshu Hemant, and Hemant Sharma serve as directors at the Company.
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U33110UP2010PTC041224
- Company No.
041224
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jul 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Pharma
Who are the key members and board of directors at Boson Remedies?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Himanshu Hemant  | Director | 08-Jan-2016 | Current |
| Uma Sharma | Director | 01-Jul-2010 | Current |
| Hemant Sharma | Director | 01-Jul-2010 | Current |
Financial Performance of Boson Remedies.
Boson Remedies Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 51.5% decrease. The company also saw a substantial fall in profitability, with a 37.96% decrease in profit. The company's net worth moved up by a moderate rise of 9.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Boson Remedies?
In 2018, Boson Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Cura Ayurvedic & Unani Limited
Uma Sharma, Himanshu Hemant and 1 more are mutual person
- Cura Foods Private Limited
Hemant Sharma is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Boson Remedies?
Unlock and access historical data on people associated with Boson Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Boson Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Boson Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
